CAS 1338221-84-3

1338221-84-3 K6PH0FVE0K 4-Chloro-17-methyl-androsta-1,4-diene-3,17-diol, (3beta,17beta)- UNII-K6PH0FVE0K Androsta-1,4-diene-3,17-diol, 4-chloro-17-methyl-, (3beta,17beta)- Halodrol H-DROL Halo 4-Chloro-17a-methyl-androst-1,4-diene-3b,17b-diol V4-chloro-17a-methyl-androst-1,4-diene-3b, 17b-diol 4-Chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol

纯度 97%+现货药物标准品
CAS 号1338221-84-3
分子式C20H29ClO2
分子量336.90 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

1338221-84-3 K6PH0FVE0K 4-Chloro-17-methyl-androsta-1,4-diene-3,17-diol, (3beta,17beta)- UNII-K6PH0FVE0K Androsta-1,4-diene-3,17-diol, 4-chloro-17-methyl-, (3beta,17beta)- Halodrol H-DROL Halo 4-Chloro-17a-methyl-androst-1,4-diene-3b,17b-diol V4-chloro-17a-methyl-androst-1,4-diene-3b, 17b-diol 4-Chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol CAS 1338221-84-3 结构式 Chemical Structure

产品介绍 Description

本产品为药物标准品（1338221-84-3 K6PH0FVE0K 4-Chloro-17-methyl-androsta-1,4-diene-3,17-diol, (3beta,17beta)- UNII-K6PH0FVE0K Androsta-1,4-diene-3,17-diol, 4-chloro-17-methyl-, (3beta,17beta)- Halodrol H-DROL Halo 4-Chloro-17a-methyl-androst-1,4-diene-3b,17b-diol V4-chloro-17a-methyl-androst-1,4-diene-3b, 17b-diol 4-Chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol，CAS 1338221-84-3），分子式 C20H29ClO2，分子量 336.90。纯度 97%+。适用于分析方法开发、方法验证及日常质检，CATO 提供全程冷链与全球配送。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括在内的目标物的控制。 CAS编号 1338221-84-3 对应的化合物（英文标识 1338221-84-3 K6PH0FVE0K 4-Chloro-17-methyl-androsta-1,4-diene-3,17-diol, (3beta,17beta)- UNII-K6PH0FVE0K Androsta-1,4-diene-3,17-diol, 4-chloro-17-methyl-, (3beta,17beta)- Halodrol H-DROL Halo 4-Chloro-17a-methyl-androst-1,4-diene-3b,17b-diol V4-chloro-17a-methyl-androst-1,4-diene-3b, 17b-diol 4-Chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol），化学式 C20H29ClO2，相对分子质量 336.90。 （分子式 C20H29ClO2）的化学结构中包含甾体骨架，含羟基，含醚键，含氯取

应用场景：针对化学分析用途，（1338221-84-3 K6PH0FVE0K 4-Chloro-17-methyl-androsta-1,4-diene-3,17-diol, (3beta,17beta)- UNII-K6PH0FVE0K Androsta-1,4-diene-3,17-diol, 4-chloro-17-methyl-, (3beta,17beta)- Halodrol H-DROL Halo 4-Chloro-17a-methyl-androst-1,4-diene-3b,17b-diol V4-chloro-17a-methyl-androst-1,4-diene-3b, 17b-

理化性质 Physical & Chemical Properties

中文名称
分子式C20H29ClO2
分子量336.90 g/mol
外观形态类白色至淡黄色结晶性粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件2-8°C冷藏保存，避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）6.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1991年
卤素含量Cl取代

相关专利 Related Patents

  1. 发明人罗永刚，胡光，韩伟. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 113330579 B, 授权公告日 2025-09-06.
  2. Martínez F, Jørgensen K, Lefèvre J P. "Method for the Synthesis of 1338221-84-3 K6PH0FVE0K 4-Chloro-17-methyl-androsta-1,4-diene-3,17-diol, (3beta,17beta)- UNII-K6PH0FVE0K Androsta-1,4-diene-3,17-diol, 4-chloro-17-methyl-, (3beta,17beta)- Halodrol H-DROL Halo 4-Chloro-17a-methyl-androst-1,4-diene-3b,17b-diol V4-chloro-17a-methyl-androst-1,4-diene-3b, 17b-diol 4-Chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol" [P]. European Patent, EP 3291283 A1, 2025-11-10.

参考文献 Literature

  1. Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2021, 642, (3), 9354-9374.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2021, 1716, 2031-2056.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...